In our study, evaluation of CD31 expression in different subtypes of GC suggests that the IHC expression of CD31 is not associated with the histological aggressive findings, and evaluation of lymphovascular invasion through H&E and IHC (using CD31 expression) shows no significant difference. The gene discussed is PECAM1; the disease is gastric cancer.